Up to six new HBV drugs set to launch by 2027, with China driving market growth, says GlobalData
Clinical Research | News | 0 Comment | 29 May, 2019
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...Read more
Agios's Phase 3 ClarlDHy trial of TIBSOVO meet its primary endpoint
Clinical Research | News | 0 Comment | 28 May, 2019
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...Read more
Takeda announces results of Phase 3b VARSITY studies
Clinical Research | News | 0 Comment | 20 May, 2019
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...Read more
Study demonstrates Clinical Utility of Liquid Biopsy for Cancer Monitoring
Clinical Research | News | 0 Comment | 17 May, 2019
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with...Read more
Clinical Research | News | 0 Comment | 15 May, 2019
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...Read more
Promethera Biosciences makes progress in HepaStem development programme
Clinical Research | News | 0 Comment | 09 May, 2019
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...Read more
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring
Clinical Research | News | 0 Comment | 08 May, 2019
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...Read more
AstraZeneca’s Calquence phase III ASCEND trial meets positive result
Clinical Research | News | 0 Comment | 08 May, 2019
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...Read more
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response
Clinical Research | News | 0 Comment | 08 May, 2019
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...Read more
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints
Clinical Research | News | 0 Comment | 08 May, 2019
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...Read more
VolitionRx initiates clinical trial programme in lung cancer
Clinical Research | News | 0 Comment | 08 May, 2019
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...Read more
Clinical research is becoming more disintegrated with the influx of data from different sources
Clinical Research | Opinion | 0 Comment | 07 May, 2019
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...Read more
Clinical Research | News | 0 Comment | 03 May, 2019
Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...Read more
NMPA approves Sinovant's clinical trial application for Derazantinib
Clinical Research | News | 0 Comment | 30 Apr, 2019
Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...Read more
ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD
Clinical Research | News | 0 Comment | 26 Apr, 2019
ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...Read more
CMD LLC wins AU$1 million grant award from FightMND
Clinical Research | News | 0 Comment | 18 Apr, 2019
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...Read more
Zydus Cadila announces phase III trial of Desidustat
Clinical Research | News | 0 Comment | 17 Apr, 2019
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...Read more
CStone Pharmaceuticals announces dosing in Ph III trial for treating adenocarcinoma
Clinical Research | News | 0 Comment | 16 Apr, 2019
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...Read more